We've found
25,125
archived clinical trials in
Diabetes
We've found
25,125
archived clinical trials in
Diabetes
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Updated: 4/24/2017
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials